Trial site
Budai Irgalmasrendi Korhaz Nonprofit Kft.
Budapest, 1027, HungaryEU-13 widening countryNot linked to an institution yet
- 1running trial
- 6closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Phase
- Phase 24 trials
- Phase 33 trials
- Status
- Completed6 trials
- Active, not recruiting1 trial
- Lead sponsor
- AbbVie2 trials
- AstraZeneca1 trial
- Immunemed Inc.1 trial
- Immunovant Sciences GmbH1 trial
- Janssen Research & Development, LLC1 trial
- and 1 more
Closed trials
Completed
A Phase 2a multi-center, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of
Burfiralimab (hzVSF-v13) added to disease-modifying antirheumatic drugs in patient with moderate to severe Rheumatoid Arthritis
2023-507944-35-00· Phase 2· Immunemed Inc.· Source
Completed
A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis
NCT06028438· Phase 2· Janssen Research & Development, LLC· Source
Completed
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis
NCT05814627· Phase 3· AbbVie· Source
Active, not recruiting
Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)
NCT05270668· Phase 2· Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)· Source
Active, not recruiting
Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus
NCT04877691· Phase 3· AstraZeneca· Source
Completed
A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis
NCT04169373· Phase 3· AbbVie· Source
Report an error